Volume | 23,493 |
|
|||||
News | - | ||||||
Day High | 10.95 | Low High |
|||||
Day Low | 10.4098 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Curis Inc | CRIS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
10.95 | 10.4098 | 10.95 | 10.87 | 10.87 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
445 | 23,493 | $ 10.76 | $ 252,826 | - | 3.80 - 20.00 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:00 | 3,702 | $ 10.87 | USD |
Curis Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
64.07M | 5.89M | - | 10.02M | -47.41M | -8.04 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Curis News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRIS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 10.26 | 11.0681 | 10.02 | 10.66 | 20,683 | 0.61 | 5.95% |
1 Month | 9.89 | 11.0681 | 9.70 | 10.28 | 20,256 | 0.98 | 9.91% |
3 Months | 14.32 | 14.5731 | 8.24 | 10.48 | 32,938 | -3.45 | -24.09% |
6 Months | 8.80 | 15.11 | 3.80 | 9.16 | 72,358 | 2.07 | 23.52% |
1 Year | 10.892 | 20.00 | 3.80 | 13.88 | 201,569 | -0.022 | -0.20% |
3 Years | 225.40 | 348.00 | 3.80 | 92.70 | 1,449,689 | -214.53 | -95.18% |
5 Years | 39.40 | 348.00 | 3.80 | 99.34 | 1,649,199 | -28.53 | -72.41% |
Curis Description
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge. |